← All stocks

Axsome Therapeutics, Inc.

AXSM Scheduled selling only

CIK 0001579428 #896 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$2.09M

$0.00 on a plan · $2.09M straight out of an exercise

Sold at will

$0.00

0 of 1 sales

Net

−$2.09M

$0.00 against sales at will

By person

9 insiders · 1 transaction

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Jacobson Mark L.

Chief Operating Officer

—

$2.09M (1) scheduled

−$2.09M

0.0000%

$0.00

−100.0%

JEFFS ROGER

Director

—

58,367

0.1114%

$12.18M

−65.2%

Pizzie Nick

Chief Financial Officer

—

42,867

0.0818%

$8.94M

0.0%

Coleman Mark

Director

—

30,389

0.0580%

$6.34M

+108.1%

Saad Mark E

Director

—

11,431

0.0218%

$2.39M

+14.3%

TABUTEAU HERRIOT

Chief Executive Officer

—

7,229

0.0138%

$1.51M

0.0%

Mahony Susan

Director

—

829

0.0016%

$172.97K

—

Maizel Ari

Chief Commercial Officer

—

0.0000%

$0.00

—

Murdock Hunter R.

General Counsel

—

0.0000%

$0.00

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Jacobson Mark L.

3 Sep 2026

Chief Operating Officer

Sold after exercise

10,000

$208.65

$2.09M

What was left out

Form 4 filings counted 1

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 1

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 10,000

History held since 17 Mar 2017